$2.59
-0.16-5.82%
Pre-Market: Nov 18, 7:00 AM EDT
Comments
Loading...
OncoCyte (NASDAQ:OCX) Stock, Earnings Estimates, EPS, And Revenue
OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-0.410
Quarterly Revenue
$115K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$709K
Analyze the earnings history of OncoCyte using advanced sorting and filters.
Data brought to you by Benzinga APIs
OncoCyte (OCX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $-0.41 | $-0.44 | 6.82 % |
| Jun 2024 | 2024-08-08 | $-0.36 | $-0.56 | 35.7 % |
| Mar 2024 | 2024-05-15 | $-1.13 | $-0.67 | -68.7 % |
| Mar 2024 | 2024-04-12 | $-2.18 | $-1.14 | -91.2 % |
OncoCyte (OCX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $115.00K | $200.00K | -42.5 % |
| Jun 2024 | 2024-08-08 | $104.00K | $320.00K | -67.5 % |
| Mar 2024 | 2024-05-15 | $176.00K | $350.00K | -49.7 % |
| Mar 2024 | 2024-04-12 | $314.00K | $320.00K | -1.88 % |
FAQ
When is OncoCyte (NASDAQ:OCX) reporting earnings?
OncoCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for OncoCyte (NASDAQ:OCX)?
OncoCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $-0.41, which beat the estimate of $-0.44.
What were OncoCyte’s (NASDAQ:OCX) revenues?
OncoCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.